Effectiveness of tolvaptan on renal replacement therapy in patients with autosomal dominant polycystic kidney disease: a retrospective cohort study from the TriNetX global collaborative network
This real-world study, employing precise matching, reveals tolvaptan's role in reducing hemodialysis initiation risk in ADPKD, despite initial hemodynamic-induced lower eGFR.
Authors
- Cheng‐Hsu Chen (ORCID: https://orcid.org/0000-0002-1299-5055)
- Ming‐Ju Wu (ORCID: https://orcid.org/0000-0002-8585-4392)
- Shang-Feng Tsai
Institutions
- National Chung Hsing University (TW)
- Tunghai University (TW)
- Taichung Veterans General Hospital (TW)
Publication Details
- Journal
- Renal Failure
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1080/0886022x.2024.2412721
- Citations
- 1
- Primary Topic
- Genetic and Kidney Cyst Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- Taichung Veterans General Hospital